Promotion of Deoxycholic Acid Effect on Colonic Cancer Cell Lines In Vitro by Altering the Mucosal Microbiota

Colorectal cancer (CRC) is the third most prevalent neoplasm and the second leading cause of cancer death worldwide. Microbiota and their products, such as bile acids (BAs), are important causal factors for the occurrence and development of CRC. Therefore, we performed 16S ribosomal RNA (16S rRNA) a...

Full description

Bibliographic Details
Published in:	Microorganisms
Main Authors:	Yanpeng Ma, Yi Zhang, Ruize Qu, Xin Zhou, Lulu Sun, Kai Wang, Changtao Jiang, Zhipeng Zhang, Wei Fu
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	colorectal cancer gut microbiota bile acid deoxycholic acid
Online Access:	https://www.mdpi.com/2076-2607/10/12/2486

Similar Items

Dietary cholesterol impairs cognition via gut microbiota-derived deoxycholic acid in obese mice
by: Yan Liu, et al.
Published: (2025-12-01)

The Effect of Deoxycholic Acid on Chitosan-Enabled Matrices for Tissue Scaffolding and Injectable Nanogels
by: Bozica Kovacevic, et al.
Published: (2022-06-01)

Gut microbiota-derived deoxycholic acid in colorectal cancer therapy: Critical considerations and an extended clinical investigation panorama analysis
by: Guomin Zhou, et al.
Published: (2025-04-01)

Deoxycholic acid inducing chronic atrophic gastritis with colonic mucosal lesion correlated to mucosal immune dysfunction in rats
by: Yuqin Cheng, et al.
Published: (2024-07-01)

Deoxycholic Acid and Cognitive Impairment and Decline in the Chronic Renal Insufficiency Cohort (CRIC)
by: Parisa Mortaji, et al.
Published: (2025-07-01)

Deoxycholic Acid Modulates Cell-Junction Gene Expression and Increases Intestinal Barrier Dysfunction
by: Huawei Zeng, et al.
Published: (2022-01-01)

Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury
by: Li Zhang, et al.
Published: (2024-12-01)

Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
by: Xiaomin Su, et al.
Published: (2023-05-01)

Deoxycholic Acid and Coronary Artery Calcification in the Chronic Renal Insufficiency Cohort
by: Anna Jovanovich, et al.
Published: (2022-04-01)

Comparative Genomic and Physiological Analysis against <i>Clostridium scindens</i> Reveals <i>Eubacterium</i> sp. c-25 as an Atypical Deoxycholic Acid Producer of the Human Gut Microbiota
by: Isaiah Song, et al.
Published: (2021-10-01)

Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis
by: Giorgio Reggiardo, et al.
Published: (2023-04-01)

Maternal Western diet mediates susceptibility of offspring to Crohn’s-like colitis by deoxycholate generation
by: Chongyang Huang, et al.
Published: (2023-05-01)

Impact of Mesotherapy with Sodium Deoxycholate on Liver: Metabolic- and Sex-Specific Insights in Swiss mice
by: LEIDYANNE F. GONÇALVES, et al.
Published: (2025-02-01)

Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease
by: Danli Yang, et al.
Published: (2021-02-01)

Research Note: Evaluation of deoxycholic acid for antihistomonal activity
by: L.C. Beer, et al.
Published: (2020-07-01)

Deoxycholic acid exacerbates intestinal inflammation by modulating interleukin-1β expression and tuft cell proportion in dextran sulfate sodium-induced murine colitis
by: Jingyi Ju, et al.
Published: (2023-02-01)

Deoxycholic Acid Mitigates Necrotic Enteritis Through Selective Inhibition of Pathobionts and Enrichment of Specific Lactic Acid Bacteria
by: Melanie A. Whitmore, et al.
Published: (2025-07-01)

A novel approach for deoxycholic acid administration to treat submental fullness: A case report assessed by 3D stereophotogrammetry
by: Victor Rogerio, et al.
Published: (2024-05-01)

Altered fecal bile acid composition in active ulcerative colitis
by: Stefanie Sommersberger, et al.
Published: (2023-11-01)

Microbial metabolite deoxycholic acid-mediated ferroptosis exacerbates high-fat diet-induced colonic inflammation
by: Chen Wang, et al.
Published: (2024-06-01)

Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
by: Ruize Qu, et al.
Published: (2023-08-01)

Microbiota-derived bile acid metabolic enzymes and their impacts on host health
by: Haohan Ma, et al.
Published: (2025-10-01)

GYY4137, as a slow-releasing H2S donor, ameliorates sodium deoxycholate–induced chronic intestinal barrier injury and gut microbiota dysbiosis
by: Shaorong Pan, et al.
Published: (2024-10-01)

Bile acids supplementation improves colonic mucosal barrier via alteration of bile acids metabolism and gut microbiota composition in goats with subacute ruminal acidosis (SARA)
by: Manman Hou, et al.
Published: (2024-11-01)

Research Progress on the Interaction between Taurine Metabolism and the Gut Microbiota
by: YANG Xinyu, WU Qingjie, MI Shengquan, ZHANG Yanzhen, GUO Junxia
Published: (2025-02-01)

Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism
by: Xue Bai, et al.
Published: (2025-06-01)

Blueberry Anthocyanins Ameliorate Hepatic Dysfunction in High-Fat Diet-Fed Mice: Association with Altered Gut Microbiota and Bile Acid Metabolism
by: Peng Xu, et al.
Published: (2025-09-01)

Integrated Metabolomic and transcriptomic analyses reveal deoxycholic acid promotes transmissible gastroenteritis virus infection by inhibiting phosphorylation of NF-κB and STAT3
by: Yajing Zhou, et al.
Published: (2024-03-01)

Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes
by: Bingting Chen, et al.
Published: (2023-12-01)

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
by: Yu-Lin Zhang, et al.
Published: (2022-09-01)

Polygonati Rhizoma Prevents Glucocorticoid‐Induced Growth Inhibition of Muscle via Promoting Muscle Angiogenesis Through Deoxycholic Acid
by: Shiyi Shi, et al.
Published: (2025-06-01)

Campylobacter jejuni benefits from the bile salt deoxycholate under low-oxygen condition in a PldA dependent manner
by: Xuefeng Cao, et al.
Published: (2023-12-01)

Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis
by: Yizhong Wang, et al.
Published: (2019-12-01)

Enhanced Emulsifying Ability of Deoxycholate through Dynamic Interaction with Layered Double Hydroxide
by: Jing Xie, et al.
Published: (2023-01-01)

Deoxycholic acid aggravates necrotizing enterocolitis through downregulation of mesenchymal-epithelial transition factor expression
by: Hongfu Li, et al.
Published: (2024-11-01)

Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota
by: Duochen Jin, et al.
Published: (2022-12-01)

Microbiota Metabolite Profiles and Dietary Intake in Older Individuals with Insomnia of Short vs. Normal Sleep Duration
by: Carmel Even, et al.
Published: (2024-03-01)

The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease
by: Zhonglin Li, et al.
Published: (2023-08-01)

Degradation of Bile Acids by Soil and Water Bacteria
by: Franziska Maria Feller, et al.
Published: (2021-08-01)

Production of New Microbially Conjugated Bile Acids by Human Gut Microbiota
by: Carlos J. Garcia, et al.
Published: (2022-05-01)